INSIGHTS ON CELL & GENE CLINICAL TRIALS
-
7 Patient Recruitment Best Practices Used By Leading Research Studies
Effective patient recruitment starts with trust. Leading trials build lasting relationships and prioritize respect, simplicity, and community engagement to overcome enrollment challenges.
-
Ease Is How Good Work Happens
Clinical research teams thrive in the Flow State, where systems align, data connects, and work becomes purposeful, not painful. Ease is clarity, not complexity.
-
The True Cost Of Tool Sprawl
Tool sprawl in clinical trials creates hidden inefficiencies, fractured collaboration, and delayed insights. Unified systems restore flow, clarity, and control across research teams and functions.
-
Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer
Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.
-
Early Phase Oncology Site Network: Benefits Of A Personal Touch
Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.
-
The Growing Complexity Of Conducting Oncology Trials
As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.
-
Investor Relations, Clinical Operations, And The Future Of Biotech Financing
Discover how integrating clinical execution with investor strategy can strengthen your position in a tougher capital landscape and accelerate your path to market.
-
Quantitative ROI With DCTs
Through dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.
-
The True ROI Of Decentralized Clinical Trials
Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.